Woodline Partners »

Alnylam Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2022-12-31 $23M 95k 237.65